Healthcare & Life Sciences Private Equity Deal Tracker: Sheridan and Morgan Stanley Recap SpendMend

Holly Buckley
McGuireWoods LLP
Contact
LinkedIn
Facebook
X
Send
Embed

Sheridan Capital Partners and Morgan Stanley Capital Partners (MSCP) have completed a recapitalization of SpendMend, according to a news release.

SpendMend, based in Grand Rapids, Mich., provides tech-enabled solutions intended to optimize the cost cycle. Founded in 1993, the company serves healthcare organizations including hospitals, pharmacies and suppliers.

Through the recapitalization, Morgan Stanley acquires a controlling interest in SpendMend while Sheridan retains a minority ownership stake.

Sheridan, based in Chicago, is healthcare-focused firm that concentrates on the lower middle market. Founded in 2012, the firm prefers to take control positions in healthcare providers and outsourced services as well as consumer health and products companies.

MSCP is the middle-market focused private equity team at Morgan Stanley Investment Management.

Sheridan originally invested in SpendMend in January 2018.

Terms of the recapitalization were not disclosed.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© McGuireWoods LLP

Written by:

McGuireWoods LLP
McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide